Inventors:
Alessandra Bartolozzi - Somerville MA, US
Stewart Campbell - Framingham MA, US
Hope Foudoulakis - Framingham MA, US
Enoch Kim - Boston MA, US
Paul Sweetnam - Marblehead MA, US
Yingfei Yang - Belmont MA, US
Assignee:
Surface Logix, Inc. - Brighton MA
International Classification:
A61K 31/4709
C07D 401/02
US Classification:
514310000, 546146000, 546148000
Abstract:
The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, particularly atherosclerosis and its clinical sequelae, for lowering serum lipids, and related ailments. The invention further relates to pharmaceutical compositions comprising the compounds and to methods of treating diseases, such as hypertriglyceridemia, hyperchylomicronemia, atherosclerosis, obesity, and related conditions using the compounds. A method for decreasing apolipoprotein B (apo B) secretion is also provided.